Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed News Paper Publication of Financial Results01-08-2024
Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed News Paper Publication of Financial ResultsGenomic Valley Biotech Ltd - 539206 - Submission Of Un-Audited Standalone Financial Results For The Quarter Ended On June 30, 2024
Please find enclosed herewith the Un- Audited Standalone financial result for the quarter ended on June 30,2024 .Genomic Valley Biotech Ltd - 539206 - Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Held On Today I.E., 29Th July, 2024
To Considered and approved the standalone Un-Audited financial results of the Company for the quarter ended 30th June, 2024. A copy of the said standalone Un-audited financial results along with the Limited review report from statuary auditor is enclosed herewith.Genomic Valley Biotech Ltd - 539206 - Board Meeting Intimation for Intimation Regarding Holding Of Board Meeting On 29Th July, 2024 To Consider Un-Audited Financial Results For The Quarter Ended June 30, 2024
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2024 ,inter alia, to consider and approve Intimation regarding Holding of Board Meeting on 29th July, 2024 to consider Un-Audited Financial Results for the quarter ended June 30, 2024Genomic Valley Biotech Ltd - 539206 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosedGenomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement regarding publication of Financial Results for the quarter and year ended March 31, 2024.Genomic Valley Biotech Ltd - 539206 - Non-Applicability Of Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Non applicability of Reg 23(9) is enclosed herewithGenomic Valley Biotech Ltd - 539206 - Audited Financial Results For The Period Ended March 31, 2024
Results are enclosed herewith:Genomic Valley Biotech Ltd - 539206 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of the Board Meeting is enclosed.